Analysis: Flawed Datasets of Monkeypox Skin Images.

J Med Syst

Bioinformatics Core, University of Luxembourg, Luxembourg Centre for Systems Biomedicine, Av. du Swing 6, Belvaux, 4367, Luxembourg.

Published: March 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The self-proclaimed first publicly available dataset of Monkeypox skin images consists of medically irrelevant images extracted from Google and photography repositories through a process denominated web-scrapping. Yet, this did not stop other researchers from employing it to build Machine Learning (ML) solutions aimed at computer-aided diagnosis of Monkeypox and other viral infections presenting skin lesions. Neither did it stop the reviewers or editors from publishing these subsequent works in peer-reviewed journals. Several of these works claimed extraordinary performance in the classification of Monkeypox, Chickenpox and Measles, employing ML and the aforementioned dataset. In this work, we analyse the initiator work that has catalysed the development of several ML solutions, and whose popularity is continuing to grow. Further, we provide a rebuttal experiment that showcases the risks of such methodologies, proving that the ML solutions do not necessarily obtain their performance from the features relevant to the diseases at issue.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024024PMC
http://dx.doi.org/10.1007/s10916-023-01928-1DOI Listing

Publication Analysis

Top Keywords

monkeypox skin
8
skin images
8
analysis flawed
4
flawed datasets
4
monkeypox
4
datasets monkeypox
4
images self-proclaimed
4
self-proclaimed publicly
4
publicly dataset
4
dataset monkeypox
4

Similar Publications

Background: Tecovirimat (TPOXX) is an antiviral authorized for the treatment of mpox infections in Canada, but recent clinical trials found it has no impact on symptom duration.

Methods: We conducted a prospective cohort study of individuals diagnosed with mpox in Toronto, Canada. Skin lesion swabs were collected weekly to quantify infectious monkeypox virus (MPXV) shedding through cell culture.

View Article and Find Full Text PDF

Mpox, caused by the monkeypox virus (MPXV), re-emerged as a significant global health issue in 2024, resulting in the declaration of a second Public Health Emergency of International Concern (PHEIC). The emergence of Clade Ib in Central Africa, particularly affecting children and immunocompromised individuals, and the ongoing global spread of Clade IIb have raised concerns about increased transmissibility and virulence, potentially driven by accelerated APOBEC3-mediated viral mutations. Novel vaccination strategies include the licensed JYNNEOS and Japan's LC16 KMB, as well as promising mRNA vaccine candidates currently in clinical trials.

View Article and Find Full Text PDF

Ibrutinib inhibits the replication of multiple poxviruses by targeting the Bruton tyrosine kinase.

J Virol

August 2025

National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.

The recent surge in global monkeypox (mpox) outbreaks highlights the critical need for developing antiviral agents targeting orthopoxvirus infections. Ibrutinib, a selective Bruton tyrosine kinase (BTK) inhibitor initially approved by the FDA in 2013 for treating chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), has emerged as a potential antiviral candidate based on a high-throughput screening for its efficacy against vaccinia virus (VACV). This study evaluated the antiviral capability of ibrutinib against VACV, mpox virus (MPXV), and lumpy skin disease virus (LSDV), demonstrating its strong antiviral activity against multiple poxviruses.

View Article and Find Full Text PDF

Mpox (formerly-monkeypox) is the second viral pit break after COVID-19. It is a zoonotic viral illness caused by an belonging to the same genus as various cowpox and vaccinia viruses. The mpox virus has two clades, clade IIb, responsible for the disease's global expansion in 2022.

View Article and Find Full Text PDF

Mpox, caused by monkeypox virus (MPXV) infection, has emerged as a significant global health threat. The World Health Organization (WHO) has twice declared a Public Health Emergency of International Concern for mpox: first for the 2022-2023 global outbreak and subsequently for concurrent outbreaks in Africa. Beyond MPXV, other members of the Orthopoxvirus genus also pose growing risks of zoonotic spillover, with the potential to jump from animal reservoirs to humans.

View Article and Find Full Text PDF